Then, we evaluated the prognostic value of CRGs by Kaplan-Meier Plotter and Cox analyses, finding that upregulated PDHA1 was associated with lower overall survival (OS) and recurrence-free survival (RFS) in BC. This evidence concerns the gene PDHA1 and breast cancer.